Likewise, CTSV expression favors distant metastasis, hence low survival rates in ERα+ breast cancer, as it facilitates cell proliferation and invasion while attenuating the expression of GATA3 through PI3K-AKT-GSK3β pathway [170] (Figure 2). The gene discussed is ESR1; the disease is breast cancer.